RGDX
Response Genetics, Inc

160
Mkt Cap
$78.00
Volume
4,300.00
52W High
$0.00
52W Low
$0.00
Price
$0.00
RGDX Fundamentals
50D MA
$0.00
Beta
0.00
Avg. Volume
0.00
Loading...
Loading...

About

Response Genetics, Inc. is engaged in the research and development of clinical diagnostic tests for cancer. Its platforms include analysis of single biomarkers using the polymerase chain reaction method as well as global gene interrogation using microarray methods from paraffin or frozen tissue specimens. It also provides pharmacogenomic testing services of clinical trial specimens to pharmaceutical companies. The company was founded by David A. Smith and Kathleen Danenberg on September 23, 1999 and is headquartered in Los Angeles, CA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A

Frequently Asked Questions

What is Market Cap of Response Genetics Inc?

Latest RGDX News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.